Atrion Corp (ATRI)

Add to Watchlists
Create an Alert
Quickflows
654.80 -15.00  -2.24% NASDAQ Apr 19, 16:58 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All ATRI News

News

View All Events

Events

Date Type Description
05/07/2020 00:00 Earnings Results Q1 2020 Earnings Results
05/21/2020 10:00 CDT Agm 2019 Annual General Meeting
06/12/2020 None Dividends 1.55 Normal, declared May 21, 2020 and paid June 30, 2020
08/06/2020 00:00 Earnings Results Q2 2020 Earnings Results
09/14/2020 None Dividends 1.75 Normal, declared August 20, 2020 and paid September 30, 2020
11/09/2020 00:00 Earnings Results Q3 2020 Earnings Results
11/30/2020 None Dividends 1.75 Normal, declared November 13, 2020 and paid December 15, 2020
02/26/2021 00:00 Earnings Results Q4 2020 Earnings Results
03/12/2021 None Dividends 1.75 Normal, declared February 26, 2021 and paid March 31, 2021
05/07/2021 00:00 Earnings Results Q1 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 147.59M
Total Expenses (TTM) 111.92M
Net Income (TTM) 32.12M

Balance Sheet View Statement

Total Assets (Quarterly) 266.89M
Total Liabilities (Quarterly) 26.45M
Shareholders Equity (Quarterly) 240.44M

Cash Flow Statement View Statement

Cash from Operations (TTM) 39.22M
Cash from Investing (TTM) -30.83M
Cash from Financing (TTM) -30.99M

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.
  • URL: http://www.atrioncorp.com
  • Investor Relations URL: https://www.atrioncorp.com/investor_relations/Investor_Relations.htm
  • HQ State/Province: Texas
  • Sector: Healthcare
  • Industry: Medical Instruments & Supplies
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: May. 07, 2021
  • Last Earnings Release: Feb. 26, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Mar. 12, 2021

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 654.80
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
DFDSX DF Dent Small Cap Growth Investor 2.70%
PKSCX Virtus KAR Small-Cap Core C 1.73%
RNSC First Trust Small Cap US Equity Sel ETF 1.25%

Comparables

Edit
XTNT Xtant Medical Holdings Inc
ASXC Asensus Surgical Inc
RMED Ra Medical Systems Inc
ISR Isoray Inc
RVP Retractable Technologies Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.